Madrigal Pharmaceuticals (MDGL) PT Raised to $735 at UBS

October 14, 2026 6:49 AM

UBS analyst Ashwani Verma raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found